Key Pharmacy Recalls Sodium Chloride Inhalation Solution Due to Sterility Concerns
Key Pharmacy and Compounding Center is recalling specific lots of Sodium Chloride Inhalation Solution because the firm cannot assure the sterility of the product.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a sterile drug with a lack of sterility assurance falls under the 'Severe' category, as it poses a significant risk of infection or serious injury.
Plain-English summary
Key Pharmacy and Compounding Center is recalling specific lots of Sodium Chloride Inhalation Solution, 0.90%, 5mL Glass/Single Dose vials. The recall is being conducted due to a lack of assurance of sterility for these sterile compounded drugs.
The affected product is distributed nationwide in the U.S.A., Australia, and Canada. The specific lots involved are identified by the codes 11-29-2016@27 (Expiration 5/20/2017) and 01-25-2017@25 (Expiration 7/24/2017).
Consumers and healthcare providers should stop using the affected product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- SODIUM CHLORIDE INH PF GV 0.9% SOLN, Inhalation Solution, 0.90%, Rx only, 5mL Glass/Single Dose vial, Prepared by Key Compounding Pharmacy
- Manufacturer
- Key Pharmacy and Compounding Center
- Category
- Drug — Compounded Sterile Drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot # 11-29-2016@27
- Exp 5/20/2017
- 01-25-2017@25
- Exp 7/24/2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 79 recalled by Key Pharmacy and Compounding Center under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 79 products in this recall →Related recalls
Same manufacturer · Key Pharmacy and Compounding Center
See all →- SevereKey Pharmacy Recalls Pyridoxal-5-Phosphate Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls Sterile Compounded Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- HighKey Pharmacy Recalls Vitamin D3 Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls 5-MTHF Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls Folic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereSodium Chloride Inhalation Solution Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2014-11-12
- HighNephron Recalls Sodium Chloride Inhalation Solution Due to Sterility Concerns
FDA (Devices) · 2016-07-06
- SevereSpecialty Medicine Compounding Pharmacy Recalls 0.9% Sodium Chloride Due to Sterility Concerns
FDA (Drugs) · 2014-01-22
- SevereRed Mountain Compounding Recalls Calcium Chloride Injection Due to Sterility Concerns
FDA (Drugs) · 2019-11-13
- HighInjectable Sodium Chloride Solution Recalled Due to Sterility Concerns and Leakage
FDA (Drugs) · 2022-12-14
- SevereRed Mountain Compounding Pharmacy Recalls S-SOD Citrate Injection Due to Sterility Concerns
FDA (Drugs) · 2019-11-13